A detailed history of Acadian Asset Management LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,201 shares of ARVN stock, worth $61,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,201
Holding current value
$61,075
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.66 - $32.73 $75,735 - $104,768
3,201 New
3,201 $78,000
Q4 2019

Feb 06, 2020

SELL
$15.39 - $44.38 $45,492 - $131,187
-2,956 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$21.55 - $27.61 $63,701 - $81,615
2,956 New
2,956 $64,000
Q2 2019

Aug 08, 2019

SELL
$15.96 - $23.8 $75,889 - $113,169
-4,755 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$13.55 - $23.79 $64,430 - $113,121
4,755 New
4,755 $70,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.